# Is subclinical alcohol- and tobacco-induced toxic optic neuropathy (ATTON) a reversible entity? - URL: https://alisanburak.com/en/wcp-2026-posterler/ev0024 - Language: en - Last updated: not specified - Page title: Is subclinical alcohol- and tobacco-induced toxic optic neuropathy (ATTON) a reversible entity? | WCP 2026 Summary > A prospective cohort study is proposed to investigate whether subclinical optic neuropathy in adults with alcohol dependence reverses with abstinence over a 3-… This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev0024) Bu sayfa, 26. Dünya Psikiyatri Kongresi'nde sunulan çalışmanın yapay zekâ desteğiyle hazırlanmış Türkçe özetidir. Çalışmanın sahibi sunan yazarlardır; atıf için orijinal kaynağa başvurun. EV0024 E-PosterBağımlılıkProspektif kohort çalışması önerisi # Is subclinical alcohol- and tobacco-induced toxic optic neuropathy (ATTON) a reversible entity? IS SUBCLINICAL ALCOHOL-TOBACCO TOXIC OPTIC NEUROPATHY (ATTON) A REVERSIBLE ENTITY? Sunan: Nileswar Das Ülke: India Kurum: All India Institute of Medical Sciences Raipur, Department of Psychiatry A prospective cohort study is proposed to investigate whether subclinical optic neuropathy in adults with alcohol dependence reverses with abstinence over a 3-month follow-up; the poster contains no outcome data. The study aims to investigate whether subclinical optic neuropathy, measured by retinal nerve fiber layer thickness, is reversible over a 3-month follow-up in adults with alcohol (and tobacco) dependence who abstain from alcohol compared with those who do not. The poster presents a proposed prospective cohort study with a nested comparison arm; participants are adults diagnosed with alcohol (and tobacco) dependence according to ICD-11, and all participants receive usual care with monthly follow-up for 3 months and are grouped as abstinent or non-abstinent from alcohol. The flowchart indicates a baseline assessment of n=432 and approximately 50% attrition; clinical instruments include the AUDIT, SADQ, RCQ-TV, FTND, and MMSE; laboratory investigations include vitamin (B1, B9, B12) levels, complete blood count, AST, ALT, GGT, CDT, CRP, HbA1c, and urine testing for opioids, cannabis, and cotinine; other investigations include optical coherence tomography (OCT), visual evoked potentials (VEP), and nerve conduction studies (NCS), which are repeated at month 3. The rationale section reports that approximately 15% of adults in India (about 160 million people) consumed alcohol in the past year, approximately 30 million people live with alcohol dependence, and tobacco dependence, the most common comorbidity, occurs in up to 90%. It emphasizes that toxic optic neuropathy caused by the neurotoxic effects of alcohol and tobacco may progress to irreversible optic atrophy and permanent vision loss, but may be reversible with early diagnosis and treatment. The poster reports no findings; the study is expected to clarify whether early diagnosis and treatment can reverse subclinical optic nerve damage. The findings could guide preventive strategies to reduce irreversible vision loss by establishing the value of routine OCT screening in individuals with chronic alcohol and tobacco use. [Orijinal postere git](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/2003) Bu çalışmaya nasıl atıf yapılır? APA 7: Das, N., Mishra, P., Singh, L. K., & Khan, L. (2026, September 23-26). Is subclinical alcohol-tobacco toxic optic neuropathy (atton) a reversible entity? [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/2003 Vancouver: Das N, Mishra P, Singh LK, Khan L. Is subclinical alcohol-tobacco toxic optic neuropathy (atton) a reversible entity? [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/2003 Yazar adları ve başlık biçimi kongre sisteminden otomatik oluşturulmuştur; kullanmadan önce orijinal posterle karşılaştırın. ## Aynı konudan - [Kannabis kaynaklı psikotik bozuklukta yatışlar ve yeniden yatışlar: retrospektif bir kohort çalışması (2018 ile 2024 arası)](https://alisanburak.com/en/wcp-2026-posterler/ev0001) - [Bağımlılıklarda psikoplasti ve bütünleşik yönetim: ASAM ölçütleri kullanılarak ödül yolağının yeniden biçimlendirilmesine yönelik nörobiyolojik bir algoritma](https://alisanburak.com/en/wcp-2026-posterler/ev0003) - [Slovenya cezaevi hizmetinde depo buprenorfin uygulamasının başlatılması](https://alisanburak.com/en/wcp-2026-posterler/ev0004) - [Bağımlılıklarda metilfenidat: DEHB olan ve olmayan erişkinlerde madde kullanımı ve bağımlılık yapan davranışlara ilişkin gelişen kanıtlar](https://alisanburak.com/en/wcp-2026-posterler/ev0005) - [Malezya'da naltreksonun genişleyen klinik kullanım alanları: madde kullanımı ve madde dışı psikiyatrik bozukluklar açısından çıkarımlar](https://alisanburak.com/en/wcp-2026-posterler/ev0006) [Tüm WCP 2026 özetleri](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev0024 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim